跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 76,387 条关于
“BubbleGen CD3+ T Cell Selection Kit”
全部
76,387
临床试验
54,100
药物
6,902
机构
285
资讯
15,100
上个月
Bracco Launches BubbleGen CD3+ T Cell Selection Kit for Bead-Free Cell Therapy Manufacturing
10个月前
Third Arc Bio Partners with Adagene to Develop Masked CD3 T Cell Engagers for Solid Tumor Treatment
7个月前
Bracco Imaging Enters Cell Therapy Manufacturing with Microbubble-Based Cell Selection Technology
10个月前
Xencor Reports Initial Phase 1 Results for XmAb819 ENPP3 x CD3 Bispecific in Clear Cell Renal Cell Carcinoma
去年
uBriGene Biosciences Advances Cell Therapy Development with DMF Submission for iPSC Reprogramming Kit
10个月前
Alys Pharmaceuticals Initiates First-in-Class Mast Cell Selective c-Kit Inhibitor Trial for Chronic Urticaria
去年
Hoth Therapeutics Secures Japanese Patent for Novel Mast Cell-Targeting Platform HT-KIT
去年
Hoth Therapeutics' HT-KIT Shows Promising Preclinical Results in KIT-Driven Cancers
10个月前
T-Therapeutics Raises $91 Million Series A to Advance First-in-Class TCR-CD3 Bispecifics for Cancer and Autoimmune Disease
8个月前
Hoth Therapeutics Secures Chinese Patent for HT-KIT Cancer Program Targeting KIT Signaling Pathways
第 1 页，共 1510 页
上一页
下一页
